Advertisement

HindustanTimes Sat,30 Aug 2014

Biocon Q3 net up 9% at Rs. 93 cr

PTI  New Delhi, January 25, 2013
First Published: 12:32 IST(25/1/2013) | Last Updated: 12:34 IST(25/1/2013)

Biotechnology major Biocon on Friday posted a 9.38% increase in its consolidated net profit at Rs. 92.81 crore for the third quarter ended December 31, 2012.

Advertisement

The company had posted a net profit of Rs. 84.85 crore during the same period of previous fiscal.

Net sales of the company rose to Rs. 634.22 crore for the third quarter, as against Rs. 516.59 crore during the same period of 2011-12 fiscal.

"We have performed well across all our business verticals. We continue to gain market share for biosimilar insulins in ROW (rest of the world) markets which now accounts for a significant part of our business," Biocon chairman and managing director Kiran Mazumdar-Shaw said in a statement.

Shares of Biocon were trading at Rs. 266 on the BSE in the afternoon trade, up 0.89% from its previous close.


Advertisement
more from Business

Sun-Ranbaxy deal: CCI raises concerns about molecules mkt

The Competition Commission, which has put the multi-billion dollar Sun-Ranbaxy deal for public scrutiny, said on Friday the major issue is whether the combination would result in high market concentration of certain molecules.

markets
Advertisement
Most Popular
Advertisement
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved